產(chǎn)品詳情
Edit   Antigenic Specificity Ki-67 proliferation Marker Clone polyclonal Host Species Rabbit Reactive Species human, mouse, rat Isotype n/a Format Protein A purified Size 100ul Concentration 1ug/ul Applications IHC-P, IF(IHC-P), IF(ICC) Reviews / Ratings If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY . Description Ki-67 (Proliferation Marker) Antibody. ? Target Background: Proliferation Marker Ki67 antigen is the prototypic cell cycle related nuclear protein, expressed by proliferating cells in all phases of the active cell cycle (G1, S, G2 and M phase). It is absent in resting (G0) cells. Ki67 are useful in establishing the cell growing fraction in neoplasms (immunohistochemically quantified by determining the number of Ki67 positive cells among the total number of resting cells = Ki67 index). In neoplastic tissues the prognostic value is comparable to the tritia Immunogen KLH conjugated synthetic peptide derived from human Ki67 . Immunogen Range: 1250-1300/3256 Other Names KIA; MIB-; MIB-1; PPP1R15; Antigen KI-67; MKI67 Gene, Accession # Gene ID: 4288, SwissProt: P46013 Catalog # bs-2130R Price Order / More Info Ki-67 proliferation Marker Antibody from BIOSS ANTIBODIES Product Specific References Kim, K. et al. (2014) Acta Otolaryngol. PubMed: 24460153 // Ma, Ying-Yu, et al. (2014) Onco Targets Ther. 637-643. PubMed: 24833907 // Ye, Qiurong, et al. (2014) PLoS ONE 9.7:e103298. PubMed: 25057912 // Li, Ning, et al. (2014) Biomaterials. PubMed: 25145854 // Luo, Xiaoming, et al. (2014) Int J Pharm. PubMed: 25218185 // Pan, Danyi, et al. (2014) Biomaterials. PubMed: 25263685 // Zhao, Yuechao, et al. (2014) Mol Endocrinol. PubMed: 25321413 // Yuan, Qing, et al. (2014) Int J Nanomedicine. 9:4829-46. PubMed: 25378924 // Yang, Fangfang, et al. (2015) Eur J Pharmacol. PubMed: 25720342 // Zhang, Jing-Yao, et al. (2015) World J Gastroenterol 21.14: 4195-4209. PubMed: 25892869 // Olianas, Maria, et al. (2015) Biochem Pharmacol. PubMed: 25888927 // Luo, Xiaoming, et al. (2015) Eur J Pharm Biopharm. PubMed: 26523356 // Zhao, Yuechao, et al. (2016) Endocrinology. // Ma, Wei-Yuan, et al. (2016) Exp Ther Med. PubMed: not posted yet // Antogenelli, Cinzia, et al. (2016) Free Radic Biol Med. PubMed: 26784015 // Li, Xin, et al. (2016) Acta Biomater. PubMed: 26873366 // Drel, Viktor R., et al. (2016) FASEB J. PubMed: 27221979 // Thompson, Christopher, et al. (2017) PLoS ONE. PubMed: 28187162 // He, Nan, et al. (2017) ACS Appl Mater Interfaces. PubMed: 28876891 // Liang, Guodong, et al.(2017) Acta Histochem. PubMed: 29173982 // Ma et al. (2016) Exp.Ther.Me. 11:631-636. PubMed: 26893658 // Dong et al. (2017) Oncotarget. 8:40583-40593. PubMed: 28489564 // Wu et al. (2018) Oncol.Lett. 15:1799-1810. PubMed: 29434876 // Cuellar et al. (2014) J.Histochem.Cytochem. 62:488-498. PubMed: 24789804 // Chen et al. (2015) PLoS.One. 10:e0144845. PubMed: 26680220 // Li et al. (2016) PLoS.One. 11:e0148273. PubMed: 26848572 // Zheng et al. (2016) Sci.Rep. 6:37414. PubMed: 27857213
產(chǎn)品資料
<![CDATA[<strong id="itm00"><address id="itm00"></address></strong>]]>
<![CDATA[<th id="itm00"></th>]]> <![CDATA[<acronym id="itm00"><label id="itm00"></label></acronym>]]>
<![CDATA[<th id="itm00"></th>]]>